Citation Impact
Citing Papers
Estimating the mean and variance from the median, range, and the size of a sample
2005 Standout
Association of trial registration with the results and conclusions of published trials of new oncology drugs
2009
Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomized controlled trial
2013
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Evidence based evaluation of immuno-coagulatory interventions in critical care.
2011
Comparative Effectiveness Research: An Empirical Study of Trials Registered in ClinicalTrials.gov
2012
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
2009
A comparison of the scientific quality of publicly and privately funded randomized controlled drug trials
2010
Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients
2006
Relationship between drug company funding and outcomes of clinical psychiatric research
2006
Extent and impact of industry sponsorship conflicts of interest in dermatology research
2005
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
2002
Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials
2013
Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
2008
Benefits and barriers of accommodating intraocular lenses
2016
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
2011
Association Between Funding and Quality of Published Medical Education Research
2007
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
2014
Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor
2015
Industry-funded Positive Studies Not Associated with Better Design or Larger Size
2006
Association of Industry Sponsorship to Published Outcomes in Gastrointestinal Clinical Research
2006
Shared Decision-Making Reduces Drug Use and Psychiatric Severity in Substance-Dependent Patients
2009
The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences
2010
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Characteristics Associated with Citation Rate of the Medical Literature
2007
Non-specific low back pain
2016 Standout
Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry
2005
Comparisons of Citations in Web of Science, Scopus, and Google Scholar for Articles Published in General Medical Journals
2009 Standout
Association of Funding and Conclusions in Randomized Drug Trials
2003
A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
2014
Factors Associated with Results and Conclusions of Trials of Thiazolidinediones
2009
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
2011
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials
2007
Technology-Enhanced Simulation for Health Professions Education
2011 Standout
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Funding source and the quality of reports of chronic wounds trials: 2004 to 2011
2014
Advancing Science through Mining Libraries, Ontologies, and Communities
2011
Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others
2007
Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies
2007
Preparation of Large Monodisperse Vesicles
2009 StandoutNobel
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research
2009
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Prevention of Venous Thromboembolism
2004 Standout
Funding source, trial outcome and reporting quality: are they related? Results of a pilot study
2002
Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry‐funded studies?
2008
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Bias in toxicology
2007
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
The Effects of Industry Sponsorship on Comparator Selection in Trial Registrations for Neuropsychiatric Conditions in Children
2013
Discrepancy between Results and Abstract Conclusions in Industry- vs Nonindustry-funded Studies Comparing Topical Prostaglandins
2008
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Lack of Transparency of Clinical Trials on Endometriosis
2013
A Web-Based Tool to Support Shared Decision Making for People With a Psychotic Disorder: Randomized Controlled Trial and Process Evaluation
2013
Toxicology for the twenty-first century
2009 StandoutNature
Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis
2012
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Epidemiologic studies of adverse effects of anti‐retroviral drugs: how well is statistical power reported
2004
Erythropoietin for patients with malignant disease
2004
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia
2004
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
2011 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Organic Switches for Surfaces and Devices
2012 StandoutNobel
How pharmaceutical industry funding affects trial outcomes: Causal structures and responses
2008
Industry and evidence-based medicine: Believable or conflicted? A systematic review of the surgical literature
2011
How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?
2011
Association Between Research Sponsorship and Study Outcome in Plastic Surgery Literature
2009
Bias in Clinical Intervention Research
2006
Influence of drug company authorship and sponsorship on drug trial outcomes
2007
An Official American Thoracic Society Policy Statement: Managing Conflict of Interest in Professional Societies
2009 Standout
pH-Responsive mechanised nanoparticles gated by semirotaxanes
2009 StandoutNobel
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005
2006
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
2003 Standout
Reporting of sources of funding in systematic reviews in periodontology and implant dentistry
2014
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Real-World Evidence — What Is It and What Can It Tell Us?
2016 Standout
Industry sponsorship and research outcome
2012 Standout
The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis
2014
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
2004
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO
2011
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Self-Reported Conflicts of Interest of Authors, Trial Sponsorship, and the Interpretation of Editorials and Related Phase III Trials in Oncology
2013
A selection model for accounting for publication bias in a full network meta‐analysis
2014
Systems to rate the strength of scientific evidence.
2002
Shared Decision Making for Clients With Mental Illness
2013
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
2008
Decision aids for people facing health treatment or screening decisions
2017 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Influence of study sponsorship on head and neck cancer randomized trial results
2012
Prevalence and Outcomes of Pharmaceutical Industry—Sponsored Clinical Trials Involving Clozapine, Risperidone, or Olanzapine
2004
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry
2007
Cataracts
2017 Standout
Predicting research trends with semantic and neural networks with an application in quantum physics
2020 StandoutNobel
Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Superficial heat or cold for low back pain
2006
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
2010
The Importance of the Preservation of the Ethical Principle of Equipoise in the Design of Clinical Trials: Relative Impact of the Methodological Quality Domains on the Treatment Effect in Randomized Controlled Trials
2003
Shared decision making interventions for people with mental health conditions
2010
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Quality of Randomized Controlled Trials Reporting in the Primary Treatment of Brain Tumors
2006
Financial Relationships in Economic Analyses of Targeted Therapies in Oncology
2012
Publication bias in clinical trials due to statistical significance or direction of trial results
2009 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Industry sponsorship and research outcome
2017 Standout
Trial of an Electronic Decision Support System to Facilitate Shared Decision Making in Community Mental Health
2011
Escitalopram versus other antidepressive agents for depression
2009
Cardiovascular Complications of Cancer Therapy
2004
Works of Jared Adams being referenced
Erythropoietin, uncertainty principle and cancer related anaemia
2002
Shared Decision-Making and Evidence-Based Practice
2006
The uncertainty principle and industry-sponsored research
2000
A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK
2002
Evaluation and appraisal of randomized controlled trials in myeloma
2001
Functional assessment of accommodating intraocular lenses versus monofocal intraocular lenses in cataract surgery: Metaanalysis
2010
Shared Decision-Making Preferences of People With Severe Mental Illness
2007
Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology
2000
Shared Decision-Making Preferences of People With Severe Mental Illness
2007